Event
Webinar: Wellbridge Health — A Telehealth Solution to Prevent HF Readmissions
Learn more about how Wellbridge Health can help manage your chronically ill patients to reduce unnecessary admissions and readmissions.
January 29, 2021 - January 29, 2022
Event
Webinar: Post-TAVR MCOT™ Monitoring Indications – HRS 2020 Science
The panelists discuss risk factors associated with developing delayed high-grade AV block in post-TAVR patients and their clinical programmatic experiences using MCOT™ (Mobile Cardiac Outpatient Telemetry) monitoring immediately following hospital discharge.
June 9, 2020 - May 1, 2021
Event
Digital health strategies like telehealth will play a central role in healthcare going forward to ensure patients can access the care they need in a safe and effective manner. Join this webinar to learn how your organization can navigate this new healthcare paradigm today and in the future.
June 23, 2020 - May 1, 2021
Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.
4,000,000,000+
Processing over 4 billion heartbeats a day
1,000,000+
Monitoring over 1 Million patients per year
30,000+
Each month more than 30,000 physicians refer patients to our products
1,000,000+
Provided over 1 million reports to physicians with information for diagnosis and therapy management
50,000+
Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued
$300,000,000+
Over $300 million invested in the technology and service platform
Find product details, quick start guides and more at myheartmonitor.com.
Philips completes the acquisition of BioTelemetry, Inc.
Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring. BioTelemetry’s financial results will be consolidated as part of Philips’ Connected Care business segment as of February 9, 2021.
February 9, 2021
Philips successfully completes tender offer for BioTelemetry, Inc.
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has successfully completed its previously announced tender offer (the “Offer”) to purchase all outstanding shares of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring for USD 72.00 per share […]
Philips to Acquire BioTelemetry
Philips to acquire BioTelemetry, Inc. for USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion) Acquisition is a strong fit with Philips’ strategy to transform the delivery of healthcare: combination of Philips’ leading patient monitoring position in the hospital with BioTelemetry’s leading cardiac diagnostics and monitoring position outside the […]
December 18, 2020